Literature DB >> 9123869

Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract.

G N Milligan1, D I Bernstein.   

Abstract

The requirement for interferon-gamma (IFN gamma) in resolution of an HSV-2 vaginal infection and the cellular sources of this cytokine in the vaginal mucosa were assessed. IFN gamma levels in vaginal secretions peaked on Days 2 and 5 following HSV-2 inoculation. Natural killer (NK) cell depletion greatly diminished the early production of IFN gamma but had no significant effect on the rate of virus clearance. CD4+ T cells were primarily responsible for the second peak of IFN gamma levels and neutralization of this IFN gamma beginning 3 days after virus inoculation delayed, but did not prevent, virus clearance from the vagina. HSV-2 persisted in mice depleted of both CD4+ and CD8+ T cells while clearance was delayed in CD4+, but not CD8+ T cell-depleted mice, demonstrating the T cell dependence and predominant role of CD4+ T cells in resolution of the infection. Together, these data suggest that IFN gamma is not essential for virus clearance but plays an important role in enhancing T cell-mediated clearance mechanisms. The implication of these results is that IFN gamma produced locally in the genital tract enhances virus clearance and may ultimately be important for reducing the amount of virus available to infect sensory ganglia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9123869     DOI: 10.1006/viro.1997.8441

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  84 in total

1.  Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity.

Authors:  A M Harandi; B Svennerholm; J Holmgren; K Eriksson
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  B7 costimulation plays an important role in protection from herpes simplex virus type 2-mediated pathology.

Authors:  Lydia G Thebeau; Lynda A Morrison
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

3.  Immunization with herpes simplex virus 2 (HSV-2) genes plus inactivated HSV-2 is highly protective against acute and recurrent HSV-2 disease.

Authors:  Christopher S Morello; Michael S Levinson; Kimberly A Kraynyak; Deborah H Spector
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

4.  Cell adhesion molecule and lymphocyte activation marker expression during experimental vaginal candidiasis.

Authors:  F L Wormley; J Chaiban; P L Fidel
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

5.  Effect of the N-butanoyl glutathione (GSH) derivative and acyclovir on HSV-1 replication and Th1 cytokine expression in human macrophages.

Authors:  Alessandra Fraternale; Giuditta Fiorella Schiavano; Maria Filomena Paoletti; Linda Palma; Mauro Magnani; Giorgio Brandi
Journal:  Med Microbiol Immunol       Date:  2014-03-29       Impact factor: 3.402

6.  In vivo requirement for Atg5 in antigen presentation by dendritic cells.

Authors:  Heung Kyu Lee; Lisa M Mattei; Benjamin E Steinberg; Philipp Alberts; Yun Hee Lee; Alexander Chervonsky; Noboru Mizushima; Sergio Grinstein; Akiko Iwasaki
Journal:  Immunity       Date:  2010-02-18       Impact factor: 31.745

7.  Differential polarization of immune responses by genetic cotransfer of chemokines changes the protective immunity of DNA vaccine against pseudorabies virus.

Authors:  Hyun A Yoon; Seong Kug Eo
Journal:  Immunology       Date:  2006-11-20       Impact factor: 7.397

8.  Comparison of the host immune response to herpes simplex virus 1 (HSV-1) and HSV-2 at two different mucosal sites.

Authors:  Min Zheng; Christopher D Conrady; Julie M Ward; Katie M Bryant-Hudson; Daniel J J Carr
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

9.  An intranasal heat shock protein based vaccination strategy confers protection against mucosal challenge with herpes simplex virus.

Authors:  Christopher D Pack; Malgorzata Gierynska; Barry T Rouse
Journal:  Hum Vaccin       Date:  2008-09-28

Review 10.  Tissue instruction for migration and retention of TRM cells.

Authors:  Norifumi Iijima; Akiko Iwasaki
Journal:  Trends Immunol       Date:  2015-08-14       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.